- Consumer Products
- Latest 0.54
- Currency C$
- Change -0.01
- Percent Change -1.818 %
- Volume 70,687
- Fri Dec 20, 2013 03:59 PM EST TSX data delayed 15 minutes.
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in Canadian dollars.
|Earnings||Nov 15||$-0.02||Mar 17||$-0.02|
12 months ended Dec 21, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Spectral is a Phase III company seeking US FDA approval for its lead theranostics product for the treatment for severe sepsis and septic shock.